Get the Stockscreener App
1.18
1.60%
-0.0192
Dyadic International Inc De stock is traded at $1.18, with a volume of 86,085.
It is down -1.60% in the last 24 hours and down -5.60% over the past month.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
See More
Previous Close:
$1.1992
Open:
$1.22
24h Volume:
86,085
Relative Volume:
2.07
Market Cap:
$35.51M
Revenue:
$2.96M
Net Income/Loss:
$-6.87M
P/E Ratio:
-5.1304
EPS:
-0.23
Net Cash Flow:
$-7.49M
1W Performance:
+0.00%
1M Performance:
-5.60%
6M Performance:
+12.38%
1Y Performance:
-17.48%
1-Day Range:
$1.17
$1.28
1-Week Range:
$1.17
$1.28
52-Week Range:
$0.9257
$2.67
Dyadic International Inc De Stock (DYAI) Company Profile
Name
Dyadic International Inc De
Sector
Industry
Phone
561-743-8333
Address
1044 NORTH U.S. HIGHWAY ONE, JUPITER
Compare DYAI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 1.69 | 0 | 0 | 0 | 0 | 0.00 | |
GOODO
Gladstone Commercial Corporation
|
20.26 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1555 | 349.69M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
MOBBW
Mobilicom Limited Warrants
|
0.2267 | 318.40M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
11.00 | 205.55M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.11 | 157.18M | 0 | 0 | 0 | 0.00 |
Dyadic International Inc De Stock (DYAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-22 | Downgrade | Dawson James | Buy → Neutral |
| Dec-17-21 | Initiated | H.C. Wainwright | Buy |
Dyadic International Inc De Stock (DYAI) Latest News
Dyadic International, Inc. to Announce First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025 - Nasdaq
Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025 - Eagle-Tribune
Biotech Pioneer Dyadic Schedules Q1 2025 Earnings Call to Discuss Protein Manufacturing Progress - Stock Titan
Dyadic International director to retire in June - Investing.com Australia
Dyadic International director to retire in June By Investing.com - Investing.com India
Dyadic International Director Arindam Bose Announces Retirement - TipRanks
Dyadic International, Inc. (NASDAQ:DYAI) Sees Large Increase in Short Interest - Defense World
Captivision Inc. (NASDAQ:CAPTW) Short Interest Down 42.5% in March - Defense World
Short Interest in Capcom Co., Ltd. (OTCMKTS:CCOEF) Rises By 74.5% - Defense World
Dyadic International, Inc. CEO to Present at 2025 World Vaccine Congress on Advancements in Biomanufacturing for Vaccines - Nasdaq
Dyadic to Present at World Vaccine Congress | Washington - GlobeNewswire
Dyadic’s Earnings Call: Growth Amid Challenges - TipRanks
Dyadic Reports 2024 Year-End Financial Results and Business Updates - GlobeNewswire
Dyadic International Reports Strong 2024 Revenue Growth - TipRanks
Earnings call transcript: Dyadic Q4 2024 shows revenue beat, EPS miss - Investing.com Australia
Earnings call transcript: Dyadic Q4 2024 shows revenue beat, EPS miss By Investing.com - Investing.com South Africa
Dyadic International Inc reports results for the quarter ended December 31Earnings Summary - TradingView
DYADIC INTERNATIONAL Earnings Results: $DYAI Reports Quarterly Earnings - Nasdaq
Dyadic Boosts Revenue 20%, Lands Major Gates Foundation and CEPI Backing - Stock Titan
Specialty Enzymes Market Competitive Analysis and Growth Opportunities 2025-2032 - Newstrail
Dyadic International Inc expected to post a loss of 4 cents a shareEarnings Preview - TradingView
Dyadic (NASDAQ: DYAI) Secures $3M Gates Foundation Grant - openPR.com
Dyadic International Secures $4.5M for Vaccine Development - TipRanks
Breakthrough: New Dyadic Technology Slashes Vaccine Production Time from 6 Months to 35 Days - StockTitan
Dyadic International (DYAI) to Release Earnings on Wednesday - Defense World
Key Trend Shaping the Enzyme Stabilizer Market in 2025: Innovative Oral Enzyme Stabilizers Enhance Efficacy... - WhaTech
Short Interest in Dyadic International, Inc. (NASDAQ:DYAI) Declines By 19.9% - The AM Reporter
Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March ... - Bluefield Daily Telegraph
Biotech Leader Dyadic Sets Date for 2024 Financial Results: Key Details for Investors - StockTitan
Industrial Enzymes Market Set For 7.1% Growth, Reaching $10.14 Billion By 2029 - WhaTech
Industrial Enzymes Global Industry Forecast Report and Company Analysis 2024-2030 Featuring BASF, Advanced Enzyme Technologies, Novozymes, DuPont Danisco, DSM, Kerry, Dyadic, Associated British Foods - GlobeNewswire Inc.
Industrial Enzymes Global Industry Forecast Report and - GlobeNewswire
Key Cellulase Market Trend 2025-2034: Product Innovation In The Cellulase Market In New Report - WhaTech
Dyadic to Attend Multiple Industry Events in March - Bluefield Daily Telegraph
Can These 3 Major Biotech Events Accelerate Dyadic's Market Position? - StockTitan
Jeans to Genes - Florida Trend
3 US Penny Stocks With Market Caps Over $40M To Consider - Simply Wall St
DYAI: Looking Toward Product Revenues - Zacks Small Cap Research
Global Enzymes Market Set for Robust Growth: Projected to Reach USD 20.4 Billion by 2029 As Discussed In Ne... - WhaTech
Food Enzymes Market to grow by USD 1.04 Billion from 2025-2029, driven by rising demand from beverage industry, Report on AI's role in market transformationTechnavio - The Malaysian Reserve
Food Enzymes Market Research Report 2025-2033, Featuring - GlobeNewswire
Enzymes Market Size, Top Companies, Sales Volume and Global Share Forecast Report - WICZ
Robust Growth in Protein Hydrolysis Enzymes Market: Insights on Market Dynamics, Key Players, and Emerging Trends - openPR
Proteases Global Market Report 2025: Robust Growth, Key Players, and Emerging Trends - openPR
Dyadic Advances Protein Platform with Key Launches, Gates Foundation Backs Vaccine Research - StockTitan
Dyadic International And 2 Other US Penny Stocks To Watch - Yahoo Finance
Alcohol and Starch Enzyme Market (2024-2032): Industry - openPR
Biocatalysts Market Competition & Segment Analysis - openPR
Hyperscale Data, Inc. (NYSEAMERICAN: GPUS) Announces Distribution of Series F Exchangeable Preferred Stock - Defense World
Specialty Enzymes Industry Research Report 2024: Global - GlobeNewswire
Cellulase Market 2024 Global Trends & 2033 Forecast: Growth Insights & Analysis In The Latest Report - WhaTech
Dyadic International Inc De Stock (DYAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.39%
3.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):